Sangeetha Reddy
@smreddymd
Followers
790
Following
847
Media
63
Statuses
372
Breast cancer medical oncologist, translational researcher and clinical trialist with focus on immunotherapy and the tumor microenvironment
UT Southwestern Medical Center
Joined August 2017
Grateful to have been part of this important work on dual immune checkpoint blockade in metastatic breast cancers! Congrats to all the authors!
The #NIMBUS trial results are now published in @NatureComms 👉Nivolumab plus low-dose #ipilimumab in hypermutated HER2-negative #MetastaticBreastCancer. 🔓 https://t.co/iKfaBC5mTO ✍️@jgtzanudo @smreddymd @EmensLeisha @CarolinaAlvesC5 @s_aldubayan @hoyin_chu @nlinmd
@NabihahTayob
0
0
1
#AACR25, capturing the last night at AACR grantee award reception along with @utswcancer colleague @smreddymd ! Managed to take a photo with the one and only @AACR_CEO !Thanks the grant support from @AACR @kidneycan
1
6
67
Big congratulations @smreddymd @utswcancer !!
We congratulate Sangeetha Reddy, MD, recipient of a 2024 Victoria’s Secret Global Fund for Women’s Cancers Career Development Award, in Partnership with Pelotonia & AACR. Dr. Reddy will study the impact of CD40 agonists on the myeloid CD8 T cell axis. @VictoriasSecret @Pelotonia
1
2
11
@UTSWInternalMed #GrandRounds with @smreddymd highlighting immunotherapy for breast cancer and her translational efforts. Our breast cancer team is strong @utswcancer @UTSWHemeOnc! @CarlosArteagaMD @suzanneconzenmd @hmcarthur
0
1
6
Big congrats!!!
Read it here: https://t.co/hBngnwVgqN Happy to talk more- How can we use our lab's tools & data to help you? Led by Lily Xu @UTSWMedCenter Med student, Katilyn Saunders, and Shawn Huang @UTSWmstp. 🙏 to funders @SusanGKomen @metavivor @theNCI. Collab w/ @GRASPtweets who gave
1
0
2
Excited to share our updated pre-clinical data on combination CD40 agonist + Flt3L + Doxil in breast cancer with @PreteeshLeo. @utswcancer #aacr24
0
2
30
#SABCS23 | Poster PO2-27-12 | Genomic determinants of benefit to nivolumab + low dose ipilimumab among patients with hypermutated HER2- #MBC: Results of #NIMBUS trial. #MetastaticBreastCancer @DrRBarroso @stolaney1 @nlinmd @nabihahtayob @emittendorfmd @RMJesel @smreddymd
1
5
10
After my wonderful experience at @MDAndersonNews, I've realized there is a robust academic life beyond it. Certainly, those who remain at or return to MDA also enjoy fulfilling careers. I've learned that various cancer centers contribute uniquely to breast cancer research.
0
3
4
Tumor Agnostic Approaches to Care: @VivekSubbiah, Joshua Z. Drago, @DrMiaLevy, and Marleen Kok addressed this topic in a Clinical Workshop moderated by Sangeetha M. Reddy this afternoon at #SABCS23. @lab_kok @smreddymd @AACR @UTHealthSAMDA @OncoAlert
1
17
50
Looking forward to moderating this session and hearing some stellar talks in Stars at Night Ballroom in just a few minutes! @SABCSSanAntonio @utswcancer #sabcs23
Join us for tumor-agnostic session @SABCSSanAntonio #SABCS23. What can we as BC physicians and investigators learn from other tumor types and how best to collaborate! With stellar speakers @VivekSubbiah
0
4
16
1
2
18
The cancer #immunity cycle provides a framework to understand the series of events that generate anti-cancer immune responses. Check out this revised review that helps better understand the successes & failures of cancer #immunotherapy
https://t.co/6SOsXMKRwM
1
16
53
It is not uncommon for clinician scientists to be questioned whether they’re ‘real doctors’ or ‘true scientists’ Both The secret to a long life as a clinician scientist is the same as a long marriage. Selective deafness Great paper @ESMO_Open @DrJonLim
esmoopen.com
The clinician-scientist, or more commonly known as physician-scientist in North America, covers a wide spectrum of roles, but is essentially an individual who holds a medical degree and usually a...
6
46
154
Highlighting the important role the innate immune system plays in immunotherapy, @smreddymd delivers an excellent lecture describing the rationale for augmenting CDK4/6i and ICB with dendritic cell therapy. #DAVAHawaiiBreast
https://t.co/NoyipOB2mR
Starting Now: Immunotherapy in Breast Cancer - (Vaccine Strategies). Moderated by: Vered Stearns #DAVAHawaiiBreast
0
2
3
Excited to share our work with @avilgelm showing dendritic cell therapy augments anti-tumor immunity with CDK4/6i and immune checkpoint blockade! https://t.co/HIcEKa1Biq
2
4
19
We did it! 7 mo of training, 9 days of hiking in the mountains, the hardest thing by far I’ve done to peak Mt Kilimanjaro…soaring above the clouds & making new family along the way…learned anything can be done by going pole pole (slow) one step at a time! An amazing experience!
10
0
61
We have a post-doc position @utsw available! Please RT and DM me if interested in a position in translational breast tumor immunology and immunotherapy. We're doing very exciting work focused on enhancing antigen presentation. https://t.co/wmBMjt4uMU
#postdocjobs
1
9
16
Incredible presentation at #SABCS2022 on InteractPrint by Student Doctor Lily Xu from @ithinkichan Lab! Stellar mentorship by Dr. Chan to feature this rising star at a general session! Grateful for this incredible collaboration @smreddymd @utswcancer and excited for more to come!
0
2
12
PD1-blockade back in the game for ER+ breast cancer! 🎊Congrats to PACE trialists. 👏👏Impressive OS for pts treated with avelumab, most important no special tox in contrast to Cm7A8 and abema/pembro. aPD1 vs aPDL1? #sabcs22. #bcsm @SABCSSanAntonio
2
9
69